MAPT and Cognitive impairment: In the late 1990s, ‘mild cognitive impairment’ (MCI) was introduced as an entity defined by cognitive impairment, but not severe enough to impair daily functioning.5 It became technically possible to assess the presence of amyloid‐β and tau protein in CSF and even using nuclear imaging of the brain.